2025 second_quarter Filing
2AIncome
$20K
Filed
October 20, 2025
Lobbying Activities
Health IssuesView all
Biopharmaceutical company focused on neurodegenerative diseases, including ALS. Issues related to accelerated approval.
Contacted:Food & Drug Administration (FDA), Health & Human Services, Dept of (HHS), HOUSE OF REPRESENTATIVES, SENATE
Lobbyists (4)
mr CHRISTOPHER DAVIS
Staff Assistant, Legislative Assistant, Senior Legislative Assistant, and Legislative Director - Rep. Rick Boucher (2006-2011)
EMILY ELIZABETH WILKINSON-HOLLAND
Staff -Rep. Price (2010-11), LA: Rep. Grimm (2011-12), Rep. Black (2012-13), Sen.Vitter (2013-2015), Sen. Heller (2015-17), Policy Adv. to the Sec.- Dept of HHS (3/2017-8/2017), Sr Advisor to Administrator - Ctrs for Medicare & Medicaid (8/17- 5/19).
KIMBERLEE TRZECIAK
FDA. Dep. Commissioner; 8/23-1/25. Assoc. Commissioner Leg. Affairs; 2/2022-08/2023. House Com. Energy & Commerce: Chief Health Advisor, 2/22-4/19. Sen. Health Policy Advisor, 3/19-3/15. Rep. John D. Dingell - LD, 05/13-07/11. Sen. LA, 7/11-08/09, LA
New